CLINICAL_TRIALS
trial_result
· 2017-04-28
Clinical Trial Update: Auranofin PK Following Oral Dose Administration [Phase 1]
Summary
Phase 1 study reports the pharmacokinetics of oral Auranofin in Amoebiasis; the trial has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Amoebiasis | Phase 1 | Status: COMPLETED